The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

(Reuters) - Nearly 87,000 Americans died from drug overdose in the United States in the 12-month period ending September 2024 ...

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

Palghar: The Union health ministry has stopped operations and production of Aveo Pharmaceuticals Ltd. (Aveo) following ...

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

During that time, drug overdose deaths decreased by 4% nationwide, marking the first time overdose deaths declined since the ...

A pharmaceutical company says their new experimental drug could be an alternative to opioid-based painkillers. America’s illicit drugs are being laced with one of the deadliest opioids ever ...

In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...